Randomized trial of standard versus ClearWay-infused abciximab and thrombectomy in myocardial infarction: rationale and design of the COCTAIL II study

Conclusion: This trial will provide important mechanistic insights on the most appropriate invasive treatment strategy for patients with STEMI and significant thrombus burden, by exploiting its factorial design and reliance on sensitive OCT endpoints.
Source: Journal of Cardiovascular Medicine - Category: Cardiology Tags: Original articles: Coronary artery disease Source Type: research